10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,588,741 | +1358.7% | 499,121 | +1874.7% | 0.31% | +1547.4% |
| Q2 2023 | $1,411,412 | +61.0% | 25,276 | +60.9% | 0.02% | +26.7% |
| Q1 2023 | $876,461 | +137.6% | 15,710 | +55.2% | 0.02% | +114.3% |
| Q4 2022 | $368,846 | -47.6% | 10,122 | -59.0% | 0.01% | -41.7% |
| Q3 2022 | $704,000 | -97.3% | 24,702 | -95.6% | 0.01% | -97.4% |
| Q2 2022 | $25,679,000 | -54.6% | 567,487 | -23.7% | 0.46% | -12.4% |
| Q1 2022 | $56,579,000 | -50.4% | 743,781 | -3.0% | 0.52% | -19.5% |
| Q4 2021 | $114,167,000 | +0.8% | 766,428 | -1.5% | 0.65% | +10.7% |
| Q3 2021 | $113,224,000 | -25.6% | 777,747 | +0.1% | 0.59% | -21.4% |
| Q2 2021 | $152,118,000 | +7.5% | 776,825 | -0.6% | 0.75% | -2.1% |
| Q1 2021 | $141,476,000 | +25.4% | 781,635 | -1.9% | 0.76% | +36.2% |
| Q4 2020 | $112,806,000 | +31.4% | 796,655 | +15.7% | 0.56% | +5.9% |
| Q3 2020 | $85,856,000 | +85.2% | 688,611 | +32.6% | 0.53% | +45.7% |
| Q2 2020 | $46,367,000 | – | 519,168 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |